-
1
-
-
33646835413
-
Targeting lymphangiogenesis to prevent tumor metastasis
-
Achen MG, Mann GB, Stacker SA (2006). Targeting lymphangiogenesis to prevent tumor metastasis. Br J Cancer, 94, 1355-60.
-
(2006)
Br J Cancer
, vol.94
, pp. 1355-1360
-
-
Achen, M.G.1
Mann, G.B.2
Stacker, S.A.3
-
2
-
-
33746012247
-
Tumor lymphangiogenesis Jian-Jun Sun et al and metastatic spread-New players begin to emerge
-
Achen MG, Stacker SA (2006). Tumor lymphangiogenesis Jian-Jun Sun et al and metastatic spread-New players begin to emerge. Int J Cancer, 119, 1755-60.
-
(2006)
Int J Cancer
, vol.119
, pp. 1755-1760
-
-
Achen, M.G.1
Stacker, S.A.2
-
3
-
-
0032937233
-
Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium
-
Breiteneder-Geleff S (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am JPathol, 154,385-94.
-
(1999)
Am J Pathol
, vol.154
, pp. 385-394
-
-
Breiteneder-Geleff, S.1
-
4
-
-
0025083071
-
Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture
-
Fidler IJ (1990). Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res, 50, 6130-8.
-
(1990)
Cancer Res
, vol.50
, pp. 6130-6138
-
-
Fidler, I.J.1
-
5
-
-
0038481970
-
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
-
Fidler IJ (2003). The pathogenesis of cancer metastasis: the ' seed and soil' hypothesis revisited. Nat Rev Cancer, 3, 453-8.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 453-458
-
-
Fidler, I.J.1
-
6
-
-
2942574538
-
Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice
-
Flatmark K, Maelandsmo GM, Martinsen M, et al (2004). Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. EurJ Cancer, 40, 1593-8.
-
(2004)
Eur J Cancer
, vol.40
, pp. 1593-1598
-
-
Flatmark, K.1
Maelandsmo, G.M.2
Martinsen, M.3
-
7
-
-
0034913816
-
LYVE-1, the lymphatic system and tumor lymphangiogenesis
-
Jackson, DG, Prevo R, Clasper S, et al (2001). LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol, 22,317-21.
-
(2001)
Trends Immunol
, vol.22
, pp. 317-321
-
-
Jackson, D.G.1
Prevo, R.2
Clasper, S.3
-
8
-
-
33749028188
-
Vascular endothelial growth factor signaling pathways: therapeutic perspective
-
Kowanetz M, Ferrara N (2006). Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res, 12, 5018-22.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5018-5022
-
-
Kowanetz, M.1
Ferrara, N.2
-
9
-
-
79958178361
-
Lymphatic vessel invasion detected by the endothelial lymphatic marker D2-40 (podoplanin) is predictive of regional lymph node status and an independent prognostic factor in patients with resected esophageal cancer
-
Kozfowski M, Naumnik W, Niklinski J, et al (2011). Lymphatic vessel invasion detected by the endothelial lymphatic marker D2-40 (podoplanin) is predictive of regional lymph node status and an independent prognostic factor in patients with resected esophageal cancer. Folia Histochem Cytobiol, 49, 90-7.
-
(2011)
Folia Histochem Cytobiol
, vol.49
, pp. 90-97
-
-
Kozfowski, M.1
Naumnik, W.2
Niklinski, J.3
-
10
-
-
18544393909
-
Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis
-
Kubo H, Fujiwara T, Jussila L, et al (2000). Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood, 96, 546-53.
-
(2000)
Blood
, vol.96
, pp. 546-553
-
-
Kubo, H.1
Fujiwara, T.2
Jussila, L.3
-
11
-
-
77953678905
-
Lymphangiogenesis in cancer: current perspectives
-
Liersch R, Biermann C, Mesters RM, et al (2010). Lymphangiogenesis in cancer: current perspectives. Recent Results Cancer Res, 180, 115-35.
-
(2010)
Recent Results Cancer Res
, vol.180
, pp. 115-135
-
-
Liersch, R.1
Biermann, C.2
Mesters, R.M.3
-
12
-
-
29044448114
-
Mechanisms of lymphangiogenesis: targets for blocking the metastatic spread of cancer
-
McColl BK, Loughran SJ, Davydova N, et al (2005). Mechanisms of lymphangiogenesis: targets for blocking the metastatic spread of cancer. Curr Cancer Drug Targets, 5, 561-71.
-
(2005)
Curr Cancer Drug Targets
, vol.5
, pp. 561-571
-
-
McColl, B.K.1
Loughran, S.J.2
Davydova, N.3
-
13
-
-
34047185818
-
Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma
-
Mylona E, Alexandrou P, Mpakali A, et al (2007). Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma. Eur J Surg Oncol, 33, 294-300
-
(2007)
Eur J Surg Oncol
, vol.33
, pp. 294-300
-
-
Mylona, E.1
Alexandrou, P.2
Mpakali, A.3
-
14
-
-
77956646251
-
Lymphangiogenesis: a new player in cancer progression
-
Nagahashi M, Ramachandran S, Rashid OM, et al (2010). Lymphangiogenesis: a new player in cancer progression. World J Gastroenterol, 16, 4003-12.
-
(2010)
World J Gastroenterol
, vol.16
, pp. 4003-4012
-
-
Nagahashi, M.1
Ramachandran, S.2
Rashid, O.M.3
-
15
-
-
0035375108
-
Mouse LYVE- 1 is an endocytic receptor for hyaluronan in lymphatic endothelium
-
Prevo R, Banerji S, Ferguson DJ, et al (2001). Mouse LYVE- 1 is an endocytic receptor for hyaluronan in lymphatic endothelium. JBiolChem, 276, 19420-30
-
(2001)
J Biol Chem
, vol.276
, pp. 19420-19430
-
-
Prevo, R.1
Banerji, S.2
Ferguson, D.J.3
-
16
-
-
27144543581
-
Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer
-
Renyi-Vamos F, Tovari J, Fillinger J, et al (2005). Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res, 11, 7344-53.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 7344-7353
-
-
Renyi-Vamos, F.1
Tovari, J.2
Fillinger, J.3
-
17
-
-
41349109766
-
Orthotopic implantation mouse model and cDNA microarray analysis indicates several genes potentially involved in lymph node metastasis of colorectal cancer
-
Sasaki H, Miura K, Horii A, et al (2008). Orthotopic implantation mouse model and cDNA microarray analysis indicates several genes potentially involved in lymph node metastasis of colorectal cancer. Cancer Sci, 99, 711-9.
-
(2008)
Cancer Sci
, vol.99
, pp. 711-719
-
-
Sasaki, H.1
Miura, K.2
Horii, A.3
-
18
-
-
34948845056
-
Role of lymphangiogenesis in cancer
-
Sundar SS, Ganesan TS (2007). Role of lymphangiogenesis in cancer. J Clin Oncol, 25, 4298-307.
-
(2007)
J Clin Oncol
, vol.25
, pp. 4298-4307
-
-
Sundar, S.S.1
Ganesan, T.S.2
-
19
-
-
0035839313
-
Animal model of para-aortic lymph node metastasis
-
Tsutsumi S, Kuwano H, Morinaga N, et al (2001). Animal model of para-aortic lymph node metastasis. Cancer Lett, 169, 77-85.
-
(2001)
Cancer Lett
, vol.169
, pp. 77-85
-
-
Tsutsumi, S.1
Kuwano, H.2
Morinaga, N.3
-
20
-
-
33845727079
-
Pathways targeting tumor lymphangiogenesis
-
Wissmann C, Detmar M (2006). Pathways targeting tumor lymphangiogenesis. Clin Cancer Res, 12, 6865-8.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6865-6868
-
-
Wissmann, C.1
Detmar, M.2
-
21
-
-
35748957169
-
Potential therapeutic strategies for lymphatic metastasis
-
Zwaans BM, Bielenberg DR (2007). Potential therapeutic strategies for lymphatic metastasis. Microvasc Res, 74, 145-58.
-
(2007)
Microvasc Res
, vol.74
, pp. 145-158
-
-
Zwaans, B.M.1
Bielenberg, D.R.2
|